The Scientist

» NIH funding and culture

Most Recent

image: Self Correction

Self Correction

By | December 1, 2015

What to do when you realize your publication is fatally flawed

0 Comments

image: Agar Shortage Limits Lab Supplies

Agar Shortage Limits Lab Supplies

By | November 24, 2015

What to do when you realize your publication is fatally flawed

1 Comment

image: Following the Funding

Following the Funding

By | November 4, 2015

What to do when you realize your publication is fatally flawed

0 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2015

What to do when you realize your publication is fatally flawed

0 Comments

image: 2015 Life Sciences Salary Survey

2015 Life Sciences Salary Survey

By and | November 1, 2015

What to do when you realize your publication is fatally flawed

13 Comments

image: Scientists Skip Cell Line Validation

Scientists Skip Cell Line Validation

By | October 12, 2015

What to do when you realize your publication is fatally flawed

2 Comments

image: Debating the Value of Anonymity

Debating the Value of Anonymity

By | October 5, 2015

What to do when you realize your publication is fatally flawed

1 Comment

image: Ready, Willing, and Able

Ready, Willing, and Able

By | October 1, 2015

What to do when you realize your publication is fatally flawed

0 Comments

image: NIH Names New Extramural Research Head

NIH Names New Extramural Research Head

By | September 29, 2015

What to do when you realize your publication is fatally flawed

0 Comments

image: Study: Men Get Bigger Start-Up Packages

Study: Men Get Bigger Start-Up Packages

By | September 17, 2015

What to do when you realize your publication is fatally flawed

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech